NV
Nostrand Robert L Van
Director

Nostrand Robert L Van insider trades: SELLAS Life Sciences Group (SLS) stock buys and sales

Director, SELLAS Life Sciences Group Last trade Jun 12, 2025 135 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2012
6
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Nostrand reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 12, 2025SLS↑ Buy$15K
Jun 18, 2024ITCI↓ Sell$1.5M
Feb 27, 2024ITCI↓ Sell$1.5M
Apr 17, 2023ITCI↓ Sell$630K
Aug 11, 2022ITCI↓ Sell$1.7M
Dec 29, 2017ITCI↑ Buy$5K
Nov 30, 2012MBLX↑ Buy$21K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SLS insiders

Open-market trades in the last 12 months

About Nostrand Robert L Van's insider trades

Nostrand Robert L Van is a director at SELLAS Life Sciences Group (SLS). Since Nov 30, 2012, Nostrand has reported 3 open-market purchases worth $41K and 4 sales worth $5.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (122 filings), option exercises (8 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.